Double threshold behavior for breakup of liquid sheets.

Proc Natl Acad Sci U S A

Institut de Recherche sur les Phénomènes Hors Equilibre, Aix-Marseille Université, CNRS, Centrale Marseille, 13384 Marseille Cedex 13, France.

Published: August 2020

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430969PMC
http://dx.doi.org/10.1073/pnas.2011358117DOI Listing

Publication Analysis

Top Keywords

double threshold
4
threshold behavior
4
behavior breakup
4
breakup liquid
4
liquid sheets
4
double
1
behavior
1
breakup
1
liquid
1
sheets
1

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

Background: Cortical excitability is elevated in Alzheimer's disease (AD). Transcranial magnetic stimulation-evoked responses on electromyography (EMG) and electroencephalography (EEG) have captured this increased excitability in motor brain regions. However, it is not yet known if increased excitability is also present in the parietal lobe or the extent to which excitability is related to cognition.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Imperial College London, London, UK.

Background: Obesity is a prevalent comorbid condition that doubles the risk of Alzheimer's disease. The proposed mechanisms underlying neuronal damage involve chronic low-grade inflammation, the production of reactive oxidative species, and altered brain glucose metabolism. In Alzheimer's disease, amyloid is thought to influence tau deposition and glucose metabolism.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Alector, South San Francisco, CA, USA.

Background: The PrecivityAD® blood-test (C2N Diagnostics) predicts cerebral amyloidosis due to Alzheimer's Disease (AD). PrecivityAD® incorporates plasma Aβ42/40, age and apoE proteotype into an algorithm that generates an amyloid probability score (APS) corresponding to the likelihood of a positive amyloid PET scan, defined as ≥25 centiloid (CL). A prototype PrecivityAD algorithm validated against amyloid PET status scored by visual read (VR) was used to improve screening efficiency in INVOKE-2, a phase 2 randomized, double-blind, placebo-controlled trial evaluating TREM2-activating antibody AL002 in early AD.

View Article and Find Full Text PDF

Background: Transcutaneous stimulation of the auricular branch of the vagus nerve (tVNS) was administered to participants diagnosed with mild cognitive impairment (MCI) to improve word-list memory (primary outcome) and other cognitive skills.

Method: A randomized, double-blind, placebo-controlled crossover design was used for this trial. Participants with MCI (n = 59) were sorted into one of two sequences: Sham-tVNS or tVNS-Sham.

View Article and Find Full Text PDF

Background: The Latarjet and other bony augmentation procedures are commonly used to treat anterior shoulder instability in the setting of significant glenoid bone loss. Although several fixation strategies have been reported, the biomechanical strength of these techniques remains poorly understood.

Purpose: To perform a systematic review of the biomechanical strength of glenoid bony augmentation procedures for anterior shoulder instability.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!